Kent Lake Urges Fellow Quanterix Shareholders To Vote “AGAINST” The Dilutive, Risky Merger With Akoya Biosciences, Which Undervalues Quanterix’s Standalone Potential

Kent Lake Partners logo featuring a stylized forest scene with tall trees and a winding path.

The proposed merger devalues Quanterix and disproportionately benefits Akoya at Quanterix shareholders' expense.

The deal effectively bails out Akoya, introduces unnecessary financial and operational risks, and diverts critical cash and management attention away from Quanterix’s biggest growth opportunity: Alzheimer’s diagnostic expansion.

Quanterix stockholders deserve better than this value destructive Merger.

As such, we respectfully urge stockholders to vote “AGAINST” the Merger to preserve the Company’s clear and compelling path toward long-term value creation.

READ OUR INVESTOR PRESENTATION

ABOUT KENT LAKE

Kent Lake initially invested in Quanterix in 2022 and is currently a top three shareholder…

Green information icon with the letter 'i' inside a circle.

REASONS TO VOTE AGAINST

Kent Lake believes the proposed merger significantly undervalues Quanterix, is a shareholder-funded bailout of Akoya, and would introduce significant unnecessary risk to Quanterix’s balance sheet…

Red X mark inside a square outline

HOW TO VOTE

Kent Lake intends to file a preliminary proxy statement and accompanying GOLD universal proxy card with the SEC…

Gold ballot box icon with a voting paper being inserted.

INVESTOR CONTACT

Kent Lake PR
Ben Natter
415-237-0007
Info@kentlakecap.com

Saratoga Proxy Consulting LLC
John Ferguson / Ann Marie Mellone
212-257-1311 / 888-368-0379
Info@saratogaproxy.com

MEDIA CONTACT

Longacre Square Partners
Joe Germani / Kendall Heebink
KentLake@longacresquarepartners.com

STAY UPDATED